Atlas Spine announces full product launch of expandable cervical interbody fusion device

Atlas Spine Inc. recently announced the full product launch of its HiJak AC expandable cervical interbody fusion device.

HiJak AC was designed with more intricate cervical conditions in mind, as it is the first expandable cervical interbody fusion device on the market to offer adjustment to both height and lordosis to easily and predictably restore lordosis and balanced sagittal alignment, according to a company press release. As a result, surgeons now have the advantage to intraoperatively customize the device to fit their patients’ specific needs.

HiJak AC begins the first stage of new minimally invasive treatment for degenerative disc disease and deformity of the cervical spine, according to the release. Atlas will release additional technologies in the next 18 months that complement the HiJak platform. 

“It’s not just about fusion anymore. As studies and clinical evidence continue to show, the value of restoring lordosis and global sagittal balance to the cervical spine is becoming more widely recognized and prioritized by spine surgeons today. With implant options that can achieve as much as 20° of angulation, HiJak’s expandable capability plays right into this surgical objective. This kind of mechanical advantage was unavailable to surgeons prior to the introduction of HiJak,” Matt Baynham, the CEO of Atlas Spine, said in the release. “We had absolute confidence in the merits of the product going into launch and the performance and feedback we’ve experienced thus far has further validated our expectations.”

 

Reference:

www.orthospinenews.com/2019/02/27/atlas-spine-inc-completes-alpha-phase-and-announces-the-full-launch-of-its-first-to-market-hijak-ac-expandable-cervical-ibfd/

 

 

 

 

 

Atlas Spine Inc. recently announced the full product launch of its HiJak AC expandable cervical interbody fusion device.

HiJak AC was designed with more intricate cervical conditions in mind, as it is the first expandable cervical interbody fusion device on the market to offer adjustment to both height and lordosis to easily and predictably restore lordosis and balanced sagittal alignment, according to a company press release. As a result, surgeons now have the advantage to intraoperatively customize the device to fit their patients’ specific needs.

HiJak AC begins the first stage of new minimally invasive treatment for degenerative disc disease and deformity of the cervical spine, according to the release. Atlas will release additional technologies in the next 18 months that complement the HiJak platform. 

“It’s not just about fusion anymore. As studies and clinical evidence continue to show, the value of restoring lordosis and global sagittal balance to the cervical spine is becoming more widely recognized and prioritized by spine surgeons today. With implant options that can achieve as much as 20° of angulation, HiJak’s expandable capability plays right into this surgical objective. This kind of mechanical advantage was unavailable to surgeons prior to the introduction of HiJak,” Matt Baynham, the CEO of Atlas Spine, said in the release. “We had absolute confidence in the merits of the product going into launch and the performance and feedback we’ve experienced thus far has further validated our expectations.”

 

Reference:

www.orthospinenews.com/2019/02/27/atlas-spine-inc-completes-alpha-phase-and-announces-the-full-launch-of-its-first-to-market-hijak-ac-expandable-cervical-ibfd/